Depakote Sprinkle Capsules (Divalproex Sodium)

Adult dose

This medication is taken orally. The initial recommended dose is 15 mg/kg per day as valproic acid, and it can be increased by 5-10 mg/kg daily at weekly intervals until seizures are controlled or no weight-related side effects occur. The maximum recommended dose is 60 mg/kg per day. If the total daily dosage exceeds 250 mg, it should be divided. The medication can either be swallowed whole or the capsule can be opened and sprinkled over a small amount of soft food like applesauce or pudding.

This medication requires special caution in pregnant women or women of childbearing potential. Alternative treatment options should be considered first during pregnancy, and this medication should not be taken if contraception requirements are not met. Co-administration with estrogen-containing hormonal preparations may reduce the blood concentration of this drug, potentially decreasing its effectiveness, necessitating monitoring by a physician and blood concentration testing. During treatment, there is a risk of worsening mental health conditions, such as suicidal impulses or depression, so patients and caregivers should carefully observe for such symptoms. Regular liver function tests are crucial, especially in children and patients with certain diseases, due to the risk of serious liver damage. If symptoms of pancreatitis occur, such as abdominal pain, nausea, vomiting, or loss of appetite, immediate medical attention should be sought, and the medication should be discontinued if pancreatitis is confirmed. Patients at risk for urea cycle disorders or hyperammonaemia must be evaluated prior to administration, and treatment should be immediately discontinued and evaluated if such conditions are suspected. In elderly patients, symptoms of drowsiness or dehydration may be more pronounced, requiring dosage adjustment and monitoring of their condition. Due to the risk of thrombocytopenia and bleeding, regular blood tests and monitoring for signs of bleeding are essential. Co-administration with certain antibiotics may reduce the effectiveness of this medication, so concurrent use should be avoided, and caution should be exercised in patients with secondary carnitine deficiency due to the risk of symptom exacerbation. Male patients should also discontinue use of this medication three months prior to conception and ensure effective contraception, and they should avoid sperm donation during and for three months after stopping this medication. Severe skin reactions or angioedema can occur with this medication, so immediate consultation with a physician is recommended if skin abnormalities develop. Although this medication is used for various conditions such as epilepsy, mania, and migraine prevention, it should not be administered to patients with certain conditions or diseases, and should be used cautiously if necessary. Regular monitoring of liver function, blood tests, mental state, skin condition, etc., should be performed, and immediate consultation with healthcare professionals is necessary if symptom exacerbation or adverse reactions occur.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory issues accompanied by coughing and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis,

Mild side effects

• Headache
• fatigue
• fever
• nausea
• vomiting
• abdominal pain
• diarrhea
• loss of appetite
• indigestion
• constipation

This medication should be stored in a tightly closed container at room temperature below 25 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance

A blue capsule filled with white granular powder.

Package unit

30 capsules/bottle, 100 capsules/bottle